ABIVAX is an innovative biotechnology company targeting the immune system to eliminate viral diseases using its unique antiviral technology platform. ABIVAX leverages three technology platforms for drug discovery: an antiviral platform; an immune enhancement platform; a polyclonal antibody platform.